Blockchain Healthcare Summit

New York , United States

About Blockchain Healthcare Summit

Blockchain offers providers and patients greater security in communication and increased consistency across visits and treatments. Blockchain offers the pharmaceutical industry and its regulators a reliable way of tracing the sources of medications and keeping track of the testing process behind them. Insurers can rely on Blockchain to help simplify adjustments, billing, and claims.

No matter which of these categories you fall into, The Blockchain for Healthcare Opportunity Summit offers you the speakers, content, and insights needed to capitalize on Blockchain and Distributed Ledger technologies. You will leave this event ready to provide increased value and security to your customers, clients, and stakeholders.

Speakers

Suzanne Belinson
PhD, MPH, Exec Dir, Clinical Markets, Blue Cross Blue Shield Association
Joshua Ashley Klayman
Managing Member
MUNTHER BAARA
Head, New Clinical Paradigm Pfizer (USA)
Ravi Seshadri
CTO - Gennem
Ashish Atreja
CHIEF INNOVATION OFFICER, MEDICINE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
F. Dario de Martino
CO-CHAIR, BLOCKCHAIN + SMART CONTRACTS MORRISON & FOERSTER LLP
View More (17)
Wesley Donohoe
VP, PRODUCT ONE MEDICAL GROUP
Daniel Durand
CHAIRMAN & VP, CLINICAL STRATEGY LIFEBRIDGE HEALTH
Mike Edelhart
MANAGING DIRECTOR SOCIAL STARTS
Mark Elenowitz
CEO & FOUNDER TRIPOINT GLOBAL EQUITIES, LLC
Lou Ferrara
BLOCKCHAIN & AI CORPORATE ADVISOR
Mark Graves, Jr.
CO-FOUNDER, CEO, CTO MYIRE
Basker Gummadi, MS, PMP, PgMP
BLOCKCHAIN & INNOVATION LEAD BAYER HEALTHCARE
Shwen Gwee
GENERAL MANAGER, DIGITAL ACCELERATOR NOVARTIS
Ahmed Hassoon
RESEARCH ASSOCIATE & SCIENTIFIC PROJECT MANAGER JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH
David Houlding
DIRECTOR, HEALTHCARE, PRIVACY & SECURITY INTEL HEALTH & LIFE SCIENCES
Donna Houlne
US HEALTHCARE LEADER IBM GLOBAL BUSINESS SERVICES
Spencer Klein
PARTNER & CO-HEAD OF THE M&A AND LIFE SCIENCES GROUPS MORRISON & FOERSTER LLP
Aditya Kudumala
PRINICPAL DELOITTE
Kate Merton
HEAD, JLABS JOHNSON & JOHNSON
Ritesh Patel
CHIEF DIGITAL OFFICER OGILVY HEALTH & WELLNESS
Pradeep Pujari
MACHINE LEARNING ENGINEER WALMARTLABS
Giles Ward
COO HASHED HEALTH

Agenda

08:00 Breakfast & Registration

9:00 Welcome Remarks
Spencer Klein, Partner & Co-Head of the M&A and Life Sciences Groups, Morrison & Foerster LLP

09:05 - Chairs’ Opening Remark
Chairs’ Opening Remark
Our Chair will lay the groundwork for how we will provide an evidence-based exploration of Blockchain applications for the healthcare community.
Ashish Atreja, Chief Technology Engagement & Innovation Officer, Mt Sinai Hospital

09:15 - Opening Session: Blockchain Opportunities for Patient Data Donation & Clinical Research

Opening Session: Blockchain Opportunities for Patient Data Donation & Clinical Research
Clinical research is the foundation for medical innovation that can positively impact patient lives, yet significant barriers exist that inhibit the secure and efficient sharing of patient information. Through blockchain’s unique capabilities, there exists the potential to bridge the gap and provide a new platform for patients to be incentivized to share their data to support clinical research. Deloitte & Pfizer have led interactive workgroups and published perspectives on this subject and will share their learnings.
Munther Baara, Director, Clinical Innovation, Pfizer
Aditya Kudumala, Principal, Deloitte


10:00
Profit Potential of Blockchain Healthcare Initiatives
In order to roll out an innovative technology, you first have to create an environment that encourages and supports organizational innovation. J&J has built a series of “Jlabs” around the country that provide spaces and resources for creative employees to explore the true value that blockchain technology offers for major healthcare organizations.
Katherine Merton, Head JLabs, Johnson & Johnson


10:35
Blockchain for Increased Trust in Clinical Trials
Clinical trials play a huge role in pharmaceutical approvals and access. These trials, however, have a history rife with lack of repeatability, unclear processes and inaccurate documentation. Blockchain can help streamline and secure the complex series of steps involved in conducting and sharing the results of clinical trials.
Basker Gummadi, Blockchain and Innovation Lead, Bayer
Shwen Gwee, General Manager, Digital Accelerator, Novartis
Mark Graves, Co-Founder, CEO, CTO, MyIRE
Joshua Ashley Klayman, Co-Chair, Blockchain + Smart Contracts, Morrison & Foerster LLP
Moderator: Mike Edelhart, Managing Director, Social Starts

11:15 - Networking Break
Provider Licensure & Credentialing with IBM Blockchain
As care becomes more digitally connected, traditional geographic boundaries are beginning to blur. Tele-health, remote specialty consults, and the growing desire of consumers to seek out the best possible value no matter where that care is centered have made it more common for providers and consumers to collaborate across health systems or state lines. For payers and providers, the financial imperative to keep patients in-network and prevent leakage in the era of value-based care adds an additional layer of complexity to the problem of managing credentials, ensuring correct licensure, and keeping up with employment changes. Blockchain may offer a solution to these issues by keeping all members of the community instantly updated on where a provider is allowed to practice, whether or not she is accepting new patients, and what new affiliations she has formed. Accurately tracking providers as they move through their careers can improve patient safety, reduce frustration for consumers, allow employers to assess potential workers more completely, and possibly even prevent employee fraud or abuse.

12:15
Networking Luncheon

13:25
Raising Capital to Drive Blockchain for Healthcare
With over $12.5 billion raised by ICOs since their inception, and with Regulation A+ as an on ramp, the traditional venture capital raising methods seem to be continually in flux. Please join us for a compelling conversation as we explore the various alternative capital raising strategies that can be utilized by companies in the ever-evolving Blockchain space.
Spencer Klein, Partner & Co-Head of the M&A and Life Sciences Groups, Morrison & Foerster LLP
Mark Elenowitz, Founder and CEO, TriPoint Global Equities
Cass Sanford, Associate General Counsel, OTC Markets
Moderator: F. Dario de Martino, Co-Chair, Blockchain + Smart Contracts, Morrison & Foerster LLP

14:05
Innovating Responses to Diagnostic Errors
Ahmed Hassoon, Research Associate & Scientific Project Manager, Johns Hopkins Bloomberg School of Public Health

14:40
Networking Break

15:00
Evaluating the Potential of Patient Data Ownership
Blockchain offers great potential in the form of patient data ownership and transparency between providers and payers. There is currently however, no precedent for getting all of the participants in a healthcare system to cooperate and collaborate on a technological rollout of this scale. This panel will discuss the promising value of increase patient data ownership as well as some of the roadblocks on the path to blockchain transformation.
Suzanne Belinson, Executive Director, Blue Cross Blue Shield
Wes Donohoe, VP, Product, One Medical
In Conversation with: Ashish Atreja, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai, NY

15:40
Digital Identity and the Future of Provider Credentialing
Daniel Durand, VP, Clinical Strategy, Lifebridge Health
Ritesh Patel, Chief Digital Officer, Ogilvy Health & Wellness
Anthony Begando, CEO, ProCredEx
Moderator: Giles Ward, COO, Hashed Health

16:20
A Multi-Stakeholder, Multi-Ecosystem Approach to Blockchain for Healthcare
Rahul Dubey, SVP, Innovation & Solutions, AHIP

16:50
Closing Remarks
Ashish Atreja, Chief Technology Engagement & Innovation Officer, Mt Sinai Hospital

17:00
Networking Reception

18:00
Summit Concludes

Medium-

Start:
Jun 13, 2019, 8:00 AM , AEST (UTC +10)
End:
Jun 14, 2019, 6:00 PM , AEST (UTC +10)
Price:
$ 99–999
Venue:
Morrison & Foerster LLP
map
Planning an ICO? We can help with a wide range of support for all stages of your ICO